Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5

Qian Zhang,Chunlin Zhang,Changjiang Kang,Jiaran Zhu,Qingshan He,Hongwei Li,Qiang Tong,Min Wang,Linlin Zhang,Xin Xiong,Yuren Wang,Hua Qu,Hongting Zheng,Yi Zheng
DOI: https://doi.org/10.1002/advs.202405987
IF: 15.1
2024-08-21
Advanced Science
Abstract:Current study demonstrates that liraglutide significantly accelerates wound closure in diabetic mouse models by improving re‐epithelialization, collagen deposition, and extracellular matrix remodeling, and enhancing the proliferation, migration, and adhesion functions of keratinocytes. Mechanically, liraglutide directly binds to Myo1c at arginine 93, enhancing the Myo1c/Dock5 interaction by targeting Dock5 promoter and thus promoting the functions of keratinocytes. This study suggests liraglutide may serve the treatment of diabetic wound healing. Non‐healing diabetic wounds and ulcer complications, with persistent cell dysfunction and obstructed cellular processes, are leading causes of disability and death in patients with diabetes. Currently, there is a lack of guideline‐recommended hypoglycemic drugs in clinical practice, likely due to limited research and unclear mechanisms. In this study, it is demonstrated that liraglutide significantly accelerates wound closure in diabetic mouse models (db/db mice and streptozotocin‐induced mice) by improving re‐epithelialization, collagen deposition, and extracellular matrix remodeling, and enhancing the proliferation, migration, and adhesion functions of keratinocytes. However, these effects of improved healing by liraglutide are abrogated in dedicator of cytokinesis 5 (Dock5) keratinocyte‐specific knockout mice. Mechanistically, liraglutide induces cellular function through stabilization of unconventional myosin 1c (Myo1c). Liraglutide directly binds to Myo1c at arginine 93, enhancing the Myo1c/Dock5 interaction by targeting Dock5 promoter and thus promoting the proliferation, migration, and adhesion of keratinocytes. Therefore, this study provides insights into liraglutide biology and suggests it may be an effective treatment for diabetic patients with wound‐healing pathologies.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?